Answers are grounded in this paper and cite their sources.
Academic-industry research collaborations have long been a source of controversy in medicine. Advocates suggest that collaborations can focus academic researchers on important clinical and translational research problems and provide them with financial and capability-enhancing technical resources.1 Critics maintain that industry engagement distracts from, or distorts, the teaching and research missions of academia.2 Although regulatory and compliance frameworks have been established to govern these relationships, controversy continues to surround efforts to enhance industry and academia collaborations.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: